Article info
PDFCorrespondence
Correspondence on ‘Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis’
- Correspondence to Dr Liza Rajasekhar, Clinical Immunology and Rheumatology, Nizam's Institute of Medical Sciences, Hyderabad 500082, Telangana, India; lizarajasekhar{at}gmail.com
Citation
Correspondence on ‘Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis’
Publication history
- Received October 15, 2020
- Accepted October 17, 2020
- First published February 4, 2021.
Online issue publication
March 31, 2023
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.